Warning: The NCBI web site requires JavaScript to function. more...
The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.
Duran S, Peytavin G, Carrieri P, Raffi F, Ecobichon JL, Pereira E, Cassuto GP, Spire B, Leport C; Antiprotease Cohort (APROCO) study group.
AIDS. 2003 May 2;17(7):1096-9.PMID: 12700466 [PubMed - indexed for MEDLINE]Related articles
Health-related quality of life after 1 year of highly active antiretroviral therapy.
Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, François C, Chêne G, Lang JM, Moatti JP, Leport C; APROCO Study Group.
J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):38-47.PMID: 12514412 [PubMed - indexed for MEDLINE]Related articles
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.
Masquelier B, Peytavin G, Leport C, Droz C, Duran S, Verdon R, Besnier JM, Chêne G, Raffi F, Brun-Vézinet F; APROCO Study Group.
J Infect Dis. 2002 Nov 15;186(10):1503-7. Epub 2002 Oct 23.PMID: 12404170 [PubMed - indexed for MEDLINE]Related articles
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP; APROCO cohort study group.
Soc Sci Med. 2002 May;54(10):1481-96.PMID: 12061483 [PubMed - indexed for MEDLINE]Related articles
Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.
Le Moing V, Chêne G, Leport C, Lewden C, Duran S, Garré M, Masquelier B, Dupon M, Raffi F; Antiprotéases Cohorte (APROCO) Study Group.
Clin Infect Dis. 2002 Jan 15;34(2):239-47. Epub 2001 Dec 4.PMID: 11740714 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...